Growth inhibition of murine melanoma by butyric acid and dimethylsulfoxide.
Treatment of B16-F10 melanoma cells with dimethylsulfoxide (DMSO) or butyric acid (BA) inhibits cell growth and delays tumor appearance in syngeneic mice. Both agents induce morphological changes in these cells. Treatment of melanoma cells with DMSO results in a marked increase in tyrosinase activity and melanin content. BA, on the other hand, does not increase melanin content and decreases tyrosinase activity. The data show that there are marked differences in the effect of DMSO and BA on melanin biosynthesis, whereas both agents inhibit cell growth and cause a delay in tumor appearance. These findings indicate that decreased proliferation of melanoma cells and induction of melanin biosynthesis are not necessarily associated phenomena.
Nordenberg
J
J
Wasserman
L
L
Beery
E
E
Aloni
D
D
Malik
H
H
Stenzel
K H
KH
Novogrodsky
A
A
D000818:Animals; D002087:Butyrates / Q000494:pharmacology* / Q000627:therapeutic use; D020148:Butyric Acid; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D004121:Dimethyl Sulfoxide / Q000494:pharmacology* / Q000627:therapeutic use; D008543:Melanins / Q000032:analysis; D008545:Melanoma / Q000032:analysis / Q000188:drug therapy / Q000201:enzymology / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D014442:Monophenol Monooxygenase / Q000378:metabolism; D009368:Neoplasm Transplantation
D002087:Butyrates; D008543:Melanins; D020148:Butyric Acid; D014442:Monophenol Monooxygenase; D004121:Dimethyl Sulfoxide